Abstract
Summary
Urinary incontinence is the involuntary loss of urine due to a loss of bladder control. Millions of people across the world are affected by urinary incontinence, and women are more likely to be affected than men. Urinary incontinence is highly underreported, primarily due to embarrassment to speak about it. Several factors such as urinary tract infection, weakening of the pelvic floor muscles and urethral sphincters, menopause, pregnancy and childbirth, and post radical prostatectomy surgery in men lead to the development of urinary incontinence.
The global market for Implanted Urinary Incontinence Device was estimated to be worth US$ 1036 million in 2023 and is forecast to a readjusted size of US$ 1769.4 million by 2030 with a CAGR of 8.0% during the forecast period 2024-2030
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Implanted Urinary Incontinence Device, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Implanted Urinary Incontinence Device by region & country, by Type, and by Application.
The Implanted Urinary Incontinence Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Implanted Urinary Incontinence Device.
Market Segmentation
By Company
Boston Scientific
GT Urological
RBM-Med
ZEPHYR Surgical Implants
Albyn Medical
Implantica
Medtronic
InControl Medical
Atlantic Therapeutics Group
Axonics Modulation Technologies
Laborie
Micron Medical
Segment by Type:
Artificial Urinary Sphincters
Electrical Stimulation Devices
Others
Segment by Application
Hospitals and Clinics
Ambulatory Surgery Centres
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Implanted Urinary Incontinence Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Implanted Urinary Incontinence Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Implanted Urinary Incontinence Device in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Implanted Urinary Incontinence Device was estimated to be worth US$ 1036 million in 2023 and is forecast to a readjusted size of US$ 1769.4 million by 2030 with a CAGR of 8.0% during the forecast period 2024-2030
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Implanted Urinary Incontinence Device, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Implanted Urinary Incontinence Device by region & country, by Type, and by Application.
The Implanted Urinary Incontinence Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Implanted Urinary Incontinence Device.
Market Segmentation
By Company
Boston Scientific
GT Urological
RBM-Med
ZEPHYR Surgical Implants
Albyn Medical
Implantica
Medtronic
InControl Medical
Atlantic Therapeutics Group
Axonics Modulation Technologies
Laborie
Micron Medical
Segment by Type:
Artificial Urinary Sphincters
Electrical Stimulation Devices
Others
Segment by Application
Hospitals and Clinics
Ambulatory Surgery Centres
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Implanted Urinary Incontinence Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Implanted Urinary Incontinence Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Implanted Urinary Incontinence Device in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Implanted Urinary Incontinence Device Product Introduction
1.2 Global Implanted Urinary Incontinence Device Market Size Forecast
1.2.1 Global Implanted Urinary Incontinence Device Sales Value (2019-2030)
1.2.2 Global Implanted Urinary Incontinence Device Sales Volume (2019-2030)
1.2.3 Global Implanted Urinary Incontinence Device Sales Price (2019-2030)
1.3 Implanted Urinary Incontinence Device Market Trends & Drivers
1.3.1 Implanted Urinary Incontinence Device Industry Trends
1.3.2 Implanted Urinary Incontinence Device Market Drivers & Opportunity
1.3.3 Implanted Urinary Incontinence Device Market Challenges
1.3.4 Implanted Urinary Incontinence Device Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Implanted Urinary Incontinence Device Players Revenue Ranking (2023)
2.2 Global Implanted Urinary Incontinence Device Revenue by Company (2019-2024)
2.3 Global Implanted Urinary Incontinence Device Players Sales Volume Ranking (2023)
2.4 Global Implanted Urinary Incontinence Device Sales Volume by Company Players (2019-2024)
2.5 Global Implanted Urinary Incontinence Device Average Price by Company (2019-2024)
2.6 Key Manufacturers Implanted Urinary Incontinence Device Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Implanted Urinary Incontinence Device Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Implanted Urinary Incontinence Device
2.9 Implanted Urinary Incontinence Device Market Competitive Analysis
2.9.1 Implanted Urinary Incontinence Device Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Implanted Urinary Incontinence Device Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Implanted Urinary Incontinence Device as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Artificial Urinary Sphincters
3.1.2 Electrical Stimulation Devices
3.1.3 Others
3.2 Global Implanted Urinary Incontinence Device Sales Value by Type
3.2.1 Global Implanted Urinary Incontinence Device Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Implanted Urinary Incontinence Device Sales Value, by Type (2019-2030)
3.2.3 Global Implanted Urinary Incontinence Device Sales Value, by Type (%) (2019-2030)
3.3 Global Implanted Urinary Incontinence Device Sales Volume by Type
3.3.1 Global Implanted Urinary Incontinence Device Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Implanted Urinary Incontinence Device Sales Volume, by Type (2019-2030)
3.3.3 Global Implanted Urinary Incontinence Device Sales Volume, by Type (%) (2019-2030)
3.4 Global Implanted Urinary Incontinence Device Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals and Clinics
4.1.2 Ambulatory Surgery Centres
4.1.3 Others
4.2 Global Implanted Urinary Incontinence Device Sales Value by Application
4.2.1 Global Implanted Urinary Incontinence Device Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Implanted Urinary Incontinence Device Sales Value, by Application (2019-2030)
4.2.3 Global Implanted Urinary Incontinence Device Sales Value, by Application (%) (2019-2030)
4.3 Global Implanted Urinary Incontinence Device Sales Volume by Application
4.3.1 Global Implanted Urinary Incontinence Device Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Implanted Urinary Incontinence Device Sales Volume, by Application (2019-2030)
4.3.3 Global Implanted Urinary Incontinence Device Sales Volume, by Application (%) (2019-2030)
4.4 Global Implanted Urinary Incontinence Device Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Implanted Urinary Incontinence Device Sales Value by Region
5.1.1 Global Implanted Urinary Incontinence Device Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Implanted Urinary Incontinence Device Sales Value by Region (2019-2024)
5.1.3 Global Implanted Urinary Incontinence Device Sales Value by Region (2025-2030)
5.1.4 Global Implanted Urinary Incontinence Device Sales Value by Region (%), (2019-2030)
5.2 Global Implanted Urinary Incontinence Device Sales Volume by Region
5.2.1 Global Implanted Urinary Incontinence Device Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Implanted Urinary Incontinence Device Sales Volume by Region (2019-2024)
5.2.3 Global Implanted Urinary Incontinence Device Sales Volume by Region (2025-2030)
5.2.4 Global Implanted Urinary Incontinence Device Sales Volume by Region (%), (2019-2030)
5.3 Global Implanted Urinary Incontinence Device Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Implanted Urinary Incontinence Device Sales Value, 2019-2030
5.4.2 North America Implanted Urinary Incontinence Device Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Implanted Urinary Incontinence Device Sales Value, 2019-2030
5.5.2 Europe Implanted Urinary Incontinence Device Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Implanted Urinary Incontinence Device Sales Value, 2019-2030
5.6.2 Asia Pacific Implanted Urinary Incontinence Device Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Implanted Urinary Incontinence Device Sales Value, 2019-2030
5.7.2 South America Implanted Urinary Incontinence Device Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Implanted Urinary Incontinence Device Sales Value, 2019-2030
5.8.2 Middle East & Africa Implanted Urinary Incontinence Device Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Implanted Urinary Incontinence Device Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Implanted Urinary Incontinence Device Sales Value
6.2.1 Key Countries/Regions Implanted Urinary Incontinence Device Sales Value, 2019-2030
6.2.2 Key Countries/Regions Implanted Urinary Incontinence Device Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Implanted Urinary Incontinence Device Sales Value, 2019-2030
6.3.2 United States Implanted Urinary Incontinence Device Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Implanted Urinary Incontinence Device Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Implanted Urinary Incontinence Device Sales Value, 2019-2030
6.4.2 Europe Implanted Urinary Incontinence Device Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Implanted Urinary Incontinence Device Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Implanted Urinary Incontinence Device Sales Value, 2019-2030
6.5.2 China Implanted Urinary Incontinence Device Sales Value by Type (%), 2023 VS 2030
6.5.3 China Implanted Urinary Incontinence Device Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Implanted Urinary Incontinence Device Sales Value, 2019-2030
6.6.2 Japan Implanted Urinary Incontinence Device Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Implanted Urinary Incontinence Device Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Implanted Urinary Incontinence Device Sales Value, 2019-2030
6.7.2 South Korea Implanted Urinary Incontinence Device Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Implanted Urinary Incontinence Device Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Implanted Urinary Incontinence Device Sales Value, 2019-2030
6.8.2 Southeast Asia Implanted Urinary Incontinence Device Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Implanted Urinary Incontinence Device Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Implanted Urinary Incontinence Device Sales Value, 2019-2030
6.9.2 India Implanted Urinary Incontinence Device Sales Value by Type (%), 2023 VS 2030
6.9.3 India Implanted Urinary Incontinence Device Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Boston Scientific
7.1.1 Boston Scientific Company Information
7.1.2 Boston Scientific Introduction and Business Overview
7.1.3 Boston Scientific Implanted Urinary Incontinence Device Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Boston Scientific Implanted Urinary Incontinence Device Product Offerings
7.1.5 Boston Scientific Recent Development
7.2 GT Urological
7.2.1 GT Urological Company Information
7.2.2 GT Urological Introduction and Business Overview
7.2.3 GT Urological Implanted Urinary Incontinence Device Sales, Revenue and Gross Margin (2019-2024)
7.2.4 GT Urological Implanted Urinary Incontinence Device Product Offerings
7.2.5 GT Urological Recent Development
7.3 RBM-Med
7.3.1 RBM-Med Company Information
7.3.2 RBM-Med Introduction and Business Overview
7.3.3 RBM-Med Implanted Urinary Incontinence Device Sales, Revenue and Gross Margin (2019-2024)
7.3.4 RBM-Med Implanted Urinary Incontinence Device Product Offerings
7.3.5 RBM-Med Recent Development
7.4 ZEPHYR Surgical Implants
7.4.1 ZEPHYR Surgical Implants Company Information
7.4.2 ZEPHYR Surgical Implants Introduction and Business Overview
7.4.3 ZEPHYR Surgical Implants Implanted Urinary Incontinence Device Sales, Revenue and Gross Margin (2019-2024)
7.4.4 ZEPHYR Surgical Implants Implanted Urinary Incontinence Device Product Offerings
7.4.5 ZEPHYR Surgical Implants Recent Development
7.5 Albyn Medical
7.5.1 Albyn Medical Company Information
7.5.2 Albyn Medical Introduction and Business Overview
7.5.3 Albyn Medical Implanted Urinary Incontinence Device Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Albyn Medical Implanted Urinary Incontinence Device Product Offerings
7.5.5 Albyn Medical Recent Development
7.6 Implantica
7.6.1 Implantica Company Information
7.6.2 Implantica Introduction and Business Overview
7.6.3 Implantica Implanted Urinary Incontinence Device Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Implantica Implanted Urinary Incontinence Device Product Offerings
7.6.5 Implantica Recent Development
7.7 Medtronic
7.7.1 Medtronic Company Information
7.7.2 Medtronic Introduction and Business Overview
7.7.3 Medtronic Implanted Urinary Incontinence Device Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Medtronic Implanted Urinary Incontinence Device Product Offerings
7.7.5 Medtronic Recent Development
7.8 InControl Medical
7.8.1 InControl Medical Company Information
7.8.2 InControl Medical Introduction and Business Overview
7.8.3 InControl Medical Implanted Urinary Incontinence Device Sales, Revenue and Gross Margin (2019-2024)
7.8.4 InControl Medical Implanted Urinary Incontinence Device Product Offerings
7.8.5 InControl Medical Recent Development
7.9 Atlantic Therapeutics Group
7.9.1 Atlantic Therapeutics Group Company Information
7.9.2 Atlantic Therapeutics Group Introduction and Business Overview
7.9.3 Atlantic Therapeutics Group Implanted Urinary Incontinence Device Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Atlantic Therapeutics Group Implanted Urinary Incontinence Device Product Offerings
7.9.5 Atlantic Therapeutics Group Recent Development
7.10 Axonics Modulation Technologies
7.10.1 Axonics Modulation Technologies Company Information
7.10.2 Axonics Modulation Technologies Introduction and Business Overview
7.10.3 Axonics Modulation Technologies Implanted Urinary Incontinence Device Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Axonics Modulation Technologies Implanted Urinary Incontinence Device Product Offerings
7.10.5 Axonics Modulation Technologies Recent Development
7.11 Laborie
7.11.1 Laborie Company Information
7.11.2 Laborie Introduction and Business Overview
7.11.3 Laborie Implanted Urinary Incontinence Device Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Laborie Implanted Urinary Incontinence Device Product Offerings
7.11.5 Laborie Recent Development
7.12 Micron Medical
7.12.1 Micron Medical Company Information
7.12.2 Micron Medical Introduction and Business Overview
7.12.3 Micron Medical Implanted Urinary Incontinence Device Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Micron Medical Implanted Urinary Incontinence Device Product Offerings
7.12.5 Micron Medical Recent Development
8 Industry Chain Analysis
8.1 Implanted Urinary Incontinence Device Industrial Chain
8.2 Implanted Urinary Incontinence Device Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Implanted Urinary Incontinence Device Sales Model
8.5.2 Sales Channel
8.5.3 Implanted Urinary Incontinence Device Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer